0001236031-19-000007.txt : 20190412 0001236031-19-000007.hdr.sgml : 20190412 20190412163517 ACCESSION NUMBER: 0001236031-19-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190411 FILED AS OF DATE: 20190412 DATE AS OF CHANGE: 20190412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 19746670 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-04-11 0 0000725363 CEL SCI CORP CVM 0001236030 KERSTEN GEERT R 1 1 0 0 Chief Executive Officer Options 5.65 2019-04-11 4 A 0 813180 0.01 A 2029-04-10 Common Stock 813180 2574863 D Part of the options were awarded in recognition of the salary that has been deferred over an approximate 12 month period and not paid in cash. These options awarded are equal to 0.25 option for every dollar deferred. The stock options vest in three (3) equal annual installments commencing one year after the grant date. Geert Kersten 2019-04-12